Preoperative Carbohydrate Loading in Elective Surgery (PROCY)

August 5, 2016 updated by: Luca Vittorio Gianotti, University of Milano Bicocca

PREOPERATIVE ORAL CARBOHYDRATE LOADING: EFFECTS ON THE GLUCOSE METABOLISM AND POSTOPERATIVE INFECTIONS

Postoperative infectious morbidity remain the most frequent, threatening and costly event after major surgery. Maintenance of postoperative euglycemia might be a key factor to prevent such complications and given the preliminary data on the positive effect of carbohydrate load on glucose metabolism it might also be valuable in improving outcome. If this treatment will be proved effective on relevant outcome measure such as rate of infections, it might be used routinely and extensively because preoperative carbohydrates administration is cheap, simple and applicable by everyone in any surgical ward.

The aim of the trial is to evaluate if the normalization of blood glucose by means of preoperative oral administration of maltodextrine, in patients candidate to elective major surgery, may be effective in improve surgical morbidity.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

880

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Monza, Italy, 20052
        • San Gerardo Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients candidate for elective major (expected duration > 2 hrs) abdominal, urologic, and gynecologic surgery

Exclusion Criteria:

  • diagnosis of diabetes mellitus,
  • baseline plasma glucose level > 125 mg/dl,
  • pancreatic resection,
  • ASA score > 3,
  • malnutrition (loss of weight greater than 10%),
  • emergency surgery,
  • documented gastro-esophageal reflux,
  • corticosteroid therapy,
  • ongoing infection,
  • pregnancy,
  • age < 18 years,
  • denied written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: preoperative carbohydrate loading
Patients in the treatment group will receive a carbohydrate beverage (total carbohydrates equal to 12.6g/100 mL: 2.1 g monosaccharide, 10.0 g maltodextrine; 240 mOsm/L) in dose of 800 mL. Patients will be free to drink the beverage from the evening before the operation and up to 2 hours before the induction of anesthesia
a carbohydrate beverage (total carbohydrates equal to 12.6g/100 mL: 2.1 g monosaccharide, 10.0 g maltodextrine; 240 mOsm/L) in dose of 800 mL
Placebo Comparator: water
The control group will receive plain water with the same volume and timing of treatment.
The control group will receive plain water with the same volume and timing of treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
rate of postoperative complications
Time Frame: 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
rate of patients needing insulin treatment
Time Frame: 4 days
4 days
rate of total complications
Time Frame: 30 day after surgery
30 day after surgery
rate of patients needing antibiotic therapy
Time Frame: 30 days after surgery
30 days after surgery
rate of reopaeration
Time Frame: 15 days
15 days
rate of patients needing intensive care treatment
Time Frame: 15 days
15 days
length of hospital stay
Time Frame: 15 days
15 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
At least one postoperative measurement of blood glucose > 110 mL/dL e < 140
Time Frame: 15 days
15 days
At least one postoperative measurement of blood glucose > 140 mL/dL e < 180
Time Frame: 15 days
15 days
Severity of complications
Time Frame: 30 days
grading according to Clavien
30 days
Duration of intensive care treatment
Time Frame: 15 days
15 days
Duration of overall complications
Time Frame: 30 days
30 days
Duration of antibiotic therapy
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luca Gianotti, MD, PhD, Milano-Bicocca University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

July 20, 2010

First Submitted That Met QC Criteria

July 21, 2010

First Posted (Estimate)

July 22, 2010

Study Record Updates

Last Update Posted (Estimate)

August 8, 2016

Last Update Submitted That Met QC Criteria

August 5, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • PROCY
  • SIS-E (Other Grant/Funding Number: SIS-E)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on PREOP

3
Subscribe